haloperidol has been researched along with nystatin a1 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Van Hecke, E | 1 |
| Fisher, AA | 1 |
| Bian, X; Jiang, H; Ma, Z; Qu, Z; Shi, L; Wang, K; Xie, J; Zhou, Y | 1 |
1 review(s) available for haloperidol and nystatin a1
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for haloperidol and nystatin a1
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Ethylenediamine sensitivity from exposure to epoxy resin hardeners and Mycolog cream.
Topics: Adult; Aged; Dermatitis, Contact; Dermatitis, Occupational; Drug Combinations; Drug Eruptions; Epoxy Resins; Ethylenediamines; Gramicidin; Humans; Male; Neomycin; Nystatin; Ointments; Triamcinolone Acetonide | 1975 |
Allergic contact dermatitis in early infancy.
Topics: Dermatitis, Allergic Contact; Diagnosis, Differential; Diaper Rash; Drug Combinations; Epoxy Resins; Ethylenediamines; Gramicidin; Humans; Infant; Infant, Newborn; Neomycin; Nickel; Nystatin; Triamcinolone Acetonide | 1994 |
Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels.
Topics: Action Potentials; Animals; CA1 Region, Hippocampal; Catalepsy; Cyclic AMP-Dependent Protein Kinases; Dopamine; Dopaminergic Neurons; Ganglia, Spinal; Ghrelin; Haloperidol; Injections, Intraventricular; KCNQ Potassium Channels; Mice; Mice, Transgenic; Nystatin; Potassium Channel Blockers; Pyramidal Cells; Rats; Receptors, Ghrelin; Signal Transduction; Substantia Nigra; Type C Phospholipases | 2013 |